@article{oai:nagoya.repo.nii.ac.jp:02001652,
 author = {Kudo, Nobutaka and Tanaka, Akihito and Ishii, Hideki and Uemura, Yusuke and Takagi, Kensuke and Iwama, Makoto and Yoshida, Ruka and Ohashi, Taiki and Kawai, Hideki and Negishi, Yosuke and Umemoto, Norio and Tanaka, Miho and Watarai, Masato and Yoshioka, Naoki and Morishima, Itsuro and Noda, Toshiyuki and Yoshida, Yukihiko and Tatami, Yosuke and Muramatsu, Takashi and Tanaka, Toshikazu and Tashiro, Hiroshi and Takada, Yasunobu and Izawa, Hideo and Watanabe, Eiichi and Murohara, Toyoaki},
 issue = {4},
 journal = {Nagoya Journal of Medical Science},
 month = {Nov},
 note = {The outbreak of coronavirus disease 19 (COVID-19) has had a great impact on medical care. During the COVID-19 pandemic, the rate of hospital admissions has been lower and the rate of in-hospital mortality has been higher in patients with acute coronary syndrome (ACS) in Western countries. However, in Japan, it is unknown whether the COVID-19 pandemic has affected the incidence of ACS. In the study, eleven hospitals in the Tokai region participated. Among enrolled hospital, we compared the incidence of ACS during the COVID-19 pandemic (April and May, 2020) with that in equivalent months in the preceding year as the control. During the study period; April and May 2020, 248 patients with ACS were admitted. Compared to April and May 2019, a decline of 8.1% [95% confidence interval (CI) 5.2–12.1; P = 0.33] in admissions for ACS was observed between April and May 2020. There was no significant difference in the strategy for revascularization and in-hospital deaths between 2019 and 2020. In conclusion, the rate of admission for ACS slightly decreased during the COVID-19 pandemic, compared to the same months in the preceding year. Moreover, degeneration of therapeutic procedures for ACS did not occur.},
 pages = {697--703},
 title = {Prevalence of acute coronary syndrome during the pandemic of COVID-19 in the Tokai Region of Japan},
 volume = {83},
 year = {2021}
}